Phillip G. Febbo, MD in

Phillip G. Febbo, MD

Login to view DISC.
Chief Scientific Officer & Chief Medical Officer at Veracyte, Inc.
📍 Mill Valley, California, United States

Dr. Phillip Febbo is a distinguished physician-scientist serving as Chief Scientific Officer and Chief Medical Officer at Veracyte. His 25+ year career, with leadership roles at Illumina, Genomic Health, and professorships at UCSF and Duke, has been dedicated to advancing cancer care through genomics. He holds an M. D. from the University of California, San Francisco.

Dr. Febbo is passionate about improving patient outcomes through accessible diagnostics. He champions technologies like liquid biopsies to enhance early cancer detection and address healthcare disparities, dedicating time to board roles with organizations like the Reagan-Udall Foundation for the FDA to advance the field of genomic medicine.

He is a 25-year member of the American Society of Clinical Oncology (ASCO), reflecting his long-standing commitment to cancer research and care.

Read the full overview →
Experience
7 Years
Current Role
Chief Scientific Officer & Chief Medical Officer
Job Level
Leadership
Location
Mill Valley, California, United States
Personality Overview

How Phillip shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Phillip cares about

Genomic Medicine
His career across Illumina, Genomic Health, and academia has focused on embedding molecular insights and genomic testing into clinical practice to improve patient outcomes.
Prostate Cancer Genomics
As a professor at UCSF, his laboratory and clinical practice specialized in using genomics to understand the biology and clinical behavior of prostate cancer.
+5 more topics Login to view topics
Career

Work history

10-2023
Chief Scientific Officer & Chief Medical Officer
Veracyte, Inc.
6-2021
Board Member and Chair or Governance Committee
Reagan-Udall Foundation for the FDA
5-2021 - 8-2023
President
ILLUMINA FOUNDATION
3-2018 - 8-2023
Chief Medical Officer
Illumina
9-2018 - 3-2023
Board Member
ACMG - American College of Medical Genetics and Genomics Foundation
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1996 - 1999
Oncology Fellowship
Dana Farber Cancer Institute
1993 - 1996
Internal Medicine
Brigham and Women's Hospital
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Brandon Finley
Brandon Finley
CX Operations Specialist
FCP Euro
SS
Samuel S.
Vice President, Global Digital Transformation
Veracyte, Inc.
 Boris Oklander
Boris Oklander
VP of AI Science and Israeli Site Lead
Veracyte, Inc.
 Mark Tirschwell
Mark Tirschwell
Board Member
Pangea
Unlock the full playbookSee exactly how to sell to Phillip. Free, 10 seconds.